Michael Gelband’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89,350
Closed -$10.6M 1923
2025
Q4
$10.6M Buy
89,350
+31,988
+56% +$3.64M 0.08% 242
2025
Q3
$5.74M Buy
+57,362
New +$6.83M 0.06% 361
2025
Q2
Sell
-30,051
Closed -$3.84M 1813
2025
Q1
$3.84M Buy
+30,051
New +$4.32M 0.04% 500
2024
Q3
Sell
-103,762
Closed -$16.9M 1941
2024
Q2
$16.9M Buy
103,762
+101,475
+4,437% +$16.5M 0.12% 152
2024
Q1
$400K Sell
2,287
-9,022
-80% -$1.48M ﹤0.01% 1188
2023
Q4
$1.91M Buy
+11,309
New +$1.65M 0.01% 594
2022
Q3
Sell
-3,342
Closed -$405K 2162
2022
Q2
$405K Buy
+3,342
New +$420K 0.01% 1436
2021
Q1
Sell
-3,442
Closed -$407K 2444
2020
Q4
$407K Buy
+3,442
New +$402K ﹤0.01% 1371

Other funds holding NOVT

Michael Gelband's NOVT Position: Q1 2026 in Review

Michael Gelband sold out of Novanta (NOVT) in Q1 2026, closing a stake of 89,350 shares — an estimated $10.6M sold.

Michael Gelband first reported a position in NOVT in Q4 2020 and held it in 8 quarters. The position peaked at $16.9M in Q2 2024. 330 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Michael Gelband reported no remaining Novanta position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 89,350 Novanta shares in Q1 2026, an estimated $10.6M.
  • Michael Gelband first reported a position in Novanta in Q4 2020 and held it in 8 quarters.
  • Michael Gelband's Novanta position peaked at $16.9M in Q2 2024.
  • 330 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.